Triple‐combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate‐to‐severe acne in children and adolescents: Randomized phase 2 study

Topical clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel (IDP‐126) is the first fixed‐dose triple‐combination formulation in development for acne. This post hoc analysis investigated efficacy and safety of IDP‐126 in children and adolescents with moderate‐to‐severe acne.

[1]  L. Eichenfield,et al.  Management of Acne Vulgaris: A Review. , 2021, JAMA.

[2]  S. Feldman,et al.  Skin Disease in Children: Effects on Quality of Life, Stigmatization, Bullying, and Suicide Risk in Pediatric Acne, Atopic Dermatitis, and Psoriasis Patients , 2021, Children.

[3]  N. Sadick,et al.  Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug , 2021, American Journal of Clinical Dermatology.

[4]  A. Finlay,et al.  Topical preparations for the treatment of mild‐to‐moderate acne vulgaris: systematic review and network meta‐analysis * , 2021, The British journal of dermatology.

[5]  F. Chew,et al.  Systematic review of the epidemiology of acne vulgaris , 2020, Scientific Reports.

[6]  B. Sevimli Dikicier.  Topical treatment of acne vulgaris: efficiency, side effects, and adherence rate , 2019, The Journal of international medical research.

[7]  S. Aiba,et al.  Androgens modulate keratinocyte differentiation indirectly through enhancing growth factor production from dermal fibroblasts. , 2019, Journal of dermatological science.

[8]  L. Kircik,et al.  Topical Vehicle Formulations in the Treatment of Acne. , 2018, Journal of drugs in dermatology : JDD.

[9]  J. Mohawk,et al.  Adapalene/Benzoyl Peroxide Gel 0.3%/2.5%: Effective Acne Therapy Regardless of Age or Gender. , 2017, Journal of drugs in dermatology : JDD.

[10]  J. Koo,et al.  The psychosocial impact of acne, vitiligo, and psoriasis: a review , 2016, Clinical, cosmetic and investigational dermatology.

[11]  S. Feldman,et al.  Interventions to increase adherence to acne treatment , 2016, Patient preference and adherence.

[12]  J. Leyden,et al.  Guidelines of care for the management of acne vulgaris. , 2016, Journal of the American Academy of Dermatology.

[13]  F. Cook-Bolden.  Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and benzoyl peroxide (3.75%) aqueous gel in moderate or severe adolescent acne vulgaris. , 2015, The Journal of clinical and aesthetic dermatology.

[14]  C. Gustafson,et al.  Treatment of Preadolescent Acne in the United States: An Analysis of Nationally Representative Data , 2013, Pediatric dermatology.

[15]  S. Orlow,et al.  Evidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Acne , 2013, Pediatrics.

[16]  L. Gold.  Efficacy and tolerability of fixed-combination acne treatment in adolescents. , 2013, Cutis.

[17]  G. Keating.  Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel , 2011, American journal of clinical dermatology.

[18]  S. Davis,et al.  Changing Age of Acne Vulgaris Visits: Another Sign of Earlier Puberty? , 2011, Pediatric dermatology.

[19]  J. Kraft,et al.  Management of acne , 2011, Canadian Medical Association Journal.

[20]  S. Feldman,et al.  Acne vulgaris in the United States: a descriptive epidemiology. , 2010, Cutis.

[21]  S. Feldman,et al.  Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trial. , 2010, Cutis.

[22]  D. Thiboutot,et al.  A Three-Step Acne System Containing Solubilized Benzoyl Peroxide versus Benzoyl Peroxide/Clindamycin in Pediatric Patients with Acne. , 2009, The Journal of clinical and aesthetic dermatology.

[23]  A. Shalita,et al.  Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial. , 2006, Journal of drugs in dermatology : JDD.

[24]  D. Thiboutot,et al.  Health‐related quality of life among patients with facial acne − assessment of a new acne‐specific questionnaire , 2001, Clinical and experimental dermatology.

[25]  S. Feldman,et al.  Medication Adherence in Children and Adolescents with Acne Vulgaris in Medicaid: A Retrospective Study Analysis , 2016, Pediatric dermatology.

[26]  Jennifer D. Billman.  MANAGEMENT OF ACNE VULGARIS: A REVIEW , 2009 .